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Throughout development GABAB receptors (GABABRs) are widely expressed in the mammalian brain. In mature auditory brainstem
neurons, GABABRs are involved in the short-term regulation of the strength and dynamics of excitatory and inhibitory inputs, thus
modulating sound analysis. During development, GABABRs also contribute to long-term changes in input strength. Using a combination
of whole-cell patch-clamp recordings in acute brain slices and immunostainings in gerbils, we characterized developmental changes in
GABABR-mediated regulation of synaptic inputs to neurons in the medial superior olive (MSO), an auditory brainstem nucleus that
analyzes interaural time differences (ITDs). Here, we show that, before hearing onset, GABABR-mediated depression of transmitter
release is much stronger for excitation than inhibition, whereas in mature animals GABABRs mainly control the inhibition. During the
same developmental period, GABABR immunoreactivity shifts from the dendritic to the somatic region of the MSO. Furthermore, only
before hearing onset (postnatal day 12), stimulation of the fibers originating in the medial and the lateral nucleus of the trapezoid body
(MNTB and LNTB) activates GABABRs on both the inhibitory and the excitatory inputs. After hearing onset, GAD65-positive endings
devoid of glycine transporter reactivity suggest GABA release from sources other than theMNTBandLNTB. At this age, pharmacological
increase of spontaneous synaptic release activates GABABRs only on the inhibitory inputs. This indicates not only a profound inhibitory
effect ofGABABRson themajor inputs toMSOneurons inneonatal animals but also adirectmodulatory role ofGABABRs for ITDanalysis
in the MSO of adult animals.
Introduction
Neurons in the medial superior olive (MSO), a nucleus in the
mammalian auditory brainstem, analyze sound direction based
on interaural time differences (ITDs) (Goldberg and Brown,
1969; Yin and Chan, 1990; Spitzer and Semple, 1995; Brand et al.,
2002). This is achieved using a coincidence detectionmechanism,
which compares the relative arrival times of the two excitatory
inputs deriving from the contralateral and the ipsilateral antero-
ventral cochlear nucleus (AVCN) (Cant and Casseday, 1986;
Skottun, 1998). In addition, MSO neurons receive major inhibi-
tory projections originating from the medial and the lateral nu-
cleus of the trapezoid body (MNTB and LNTB) (Cant and
Hyson, 1992; Kuwabara and Zook, 1992; Grothe and Sanes,
1993) (see Fig. 1A). These inhibitory inputs adjust the output
signal of MSO neurons such that large changes in the discharge
rate are occurring within the physiological relevant range of ITDs
an animal experiences (Brand et al., 2002; Pecka et al., 2008).
In adult animals, this inhibition is mediated by glycine
(Helfert et al., 1989; Smith et al., 2000). Yet, in neonatal animals
up to postnatal day 12 (P12), GABA also represents an important
inhibitory transmitter, as MNTB fiber stimulation activates
GABAA receptor-mediated currents in neurons of the medial and
lateral superiorolive (Kotak et al., 1998; Smith et al., 2000;Kullmann
et al., 2002; Nabekura et al., 2004). In most brain regions, GABA
not only induces a chloride current via GABAA receptors but also
activates the metabotropic GABAB receptor (GABABR). On the
postsynaptic site, GABABR activation triggers a direct inhibitory
action via the activation of potassium channels (Pitler and Alger,
1994; Lu¨scher et al., 1997; Nicoll, 2004). Presynaptically situated
GABABRs modulate the release probability of inhibitory and ex-
citatory neurotransmitters by depressing Ca2 currents (Wojcik
andNeff, 1984; Isaacson, 1998; Takahashi et al., 1998). Addition-
ally, GABABRs can be indirectly involved in long-term plastic
changes of synaptic efficacy (Kotak et al., 2001; Kamikubo et al.,
2007). In the mature auditory brainstem, GABABRs primarily
contribute to the dynamic regulation of transmitter release. We
have previously shown that, in the lateral superior olive (LSO),
GABABR activation by retrogradely released GABA regulates the
balance of excitation and inhibition and thereby adjusts the sensitiv-
ityof theseneurons to interaural intensitydifferences (Magnussonet
al., 2008). Furthermore, presynaptic GABABRs have been impli-
cated in decreasing short-term synaptic depression and might
thereby improve faithful synaptic transmission for the represen-
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tation of sound structure (Brenowitz et al., 1998; Mapelli et al.,
2009). Preliminary immunostainings have revealed that in the
auditory brainstemGABABRs are not only present before hearing
onset, when theMNTB releases both GABA and glycine, but also
in adult animals, when the MNTB input has become glycinergic
(Heise et al., 2005; Hilbig et al., 2007). The primary goal of this
study was to determine whether the GABABR-mediated regula-
tion of the main excitatory and inhibitory inputs to the MSO
changes during development. Moreover, we wanted to show to
what extent endogenous GABABR activation in the MSO is al-
tered during this developmental period.
Materials andMethods
Slice preparation.All experiments were performed in conformity with the
rules set by the European Community Council Directive (86/89/ECC)
and German animal welfare legislation.
Acute transverse brain slices (140–190m) of the auditory brainstem
containing MSO, MNTB, and LNTB were obtained from male and fe-
male gerbils (Meriones unguiculatus) aged P8–P32. After decapitation
under isoflurane anesthesia, the brainstem was carefully removed and
placed in an ice-cold slice solution (see below). Slices were cut in the
rostral direction from the level of the facial nerve, with a vibratome
(VT1000S; Leica), and incubated at 32°C in oxygenated artificial CSF
(aCSF) (see below) for 5min, after which they were allowed to cool down
to room temperature (22 2°C). Recordings were obtained within 4–5
h after the preparation.
Drugs and solutions. To minimize potentially damaging Ca2 influx
into the neurons, a low-sodium, high-sucrose slice solution [containing
the following (in mM): 85 NaCl, 2.5 KCl, 1.3 NaH2PO4, 2.5 NaHCO3, 75
sucrose, 25 glucose, 0.5 CaCl2, and 4 MgCl2] was used for the slicing
procedure. The control aCSF, used for storage and recordings, was com-
posed of the following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26
NaHCO3, 25 glucose, 2 CaCl2, and 1 MgCl2. These external solutions
were bubbled continuously with carbogen gas (95% O2, 5% CO2), gen-
erating a pH of 7.4.
Whole-cell voltage-clamp recordings were performed using a Cs-
based internal solution [comprising the following (inmM): 70 CsMeSO4,
70 CsCl, 10 HEPES, 10 EGTA, 2 Na2-ATP, 2 Mg-ATP, 0.3 Na2-GTP, 1
CaCl2, and adjusted to pH 7.3 with CsOH]. Voltage-gated sodium and
potassium currents were blocked by adding QX-314 (lidocaine N-ethyl
bromide) (1mM) andTEA-Cl (tetraethylammoniumchloride) (5mM) to
the electrode solution before usage. For whole-cell current-clamp re-
cordings and for the characterization of postsynapticGABABR effects, we
used an internal solution consisting of the following (in mM): 130
K-gluconate, 5 KCl, 10 HEPES, 1 EGTA, 2 Na2-ATP, 2 Mg-ATP, 0.3
Na2-GTP, 10 Na-phosphocreatine, adjusted to pH 7.3 with KOH.
Additionally, the following pharmacological agents were used: 6,7-
dinitroquinoxaline-2,3-dione (DNQX), DL-2-amino-5-phosphonopentanoic
acid (DL-APV), 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic
acid hydrobromide (SR95531), (2S)-()-5,5-dimethyl-2-morpholineac-
etic acid (SCH50911), (R)-4-amino-3-(4-chlorophenyl)butanoic acid
[(R)-baclofen], 4-ethylphenylamino-1,2-dimethyl-6-methylamino-
pyrimidinium chloride (ZD7288) (all Tocris Bioscience), strychnine,
1-[2-[[(diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-3-pyridi-
necarboxylic acid hydrochloride hydrochloride (NO711 hydrochloride),
and4-aminopyridine(4-AP)(all Sigma-Aldrich).Alldrugsweredissolved in
dH2O and stored at 20°C. Before the experiment, aliquots were thawed
and added to the perfusate during the experiment.
Whole-cell recordings. All recordings were performed at 32°C. After
incubation, slices were transferred to a recording chamber perfused (1–2
ml/min) with oxygenated aCSF. MSO principal cells were viewed
through an upright microscope (Zeiss Axioscope) using a 40 water-
immersion objective (Achroplan; Zeiss) and infrared-differential inter-
ference optics equipped with an infrared-sensitive digital camera
(KP-M2R; Hitachi Kokusai Electric). Whole-cell voltage- and current-
clamp recordings were performed from the MSO with a Multiclamp
700A amplifier (Molecular Devices). Borosilicate glass microelectrodes
(GC150F-10; Harvard Apparatus) were pulled on a DMZ Universal
Puller (Zeitz Instruments), yielding a final tip resistance of 2–3.5 M.
The series resistance ranged from 5 to 13 M and was compensated by
70–80% for voltage-clamp recordings. Furthermore, the series resis-
tance was monitored throughout the duration of these experiments and
was not allowed to vary by 20%. For current-clamp experiments, the
bridge balance was applied.
Experimental procedure.MSO principal neurons were optically identi-
fied through the bipolar fusiform shape of their somata with dendrites
extending medially and laterally. In addition, only neurons with capaci-
ties20 pF, as read from the compensation of theMultiClamp amplifier,
were regarded as principal neurons and included in this study. Evoked
synaptic responses were elicited with a glassmicroelectrode (tip opening,
1–2 m) filled with NaCl (2 M), which was positioned in the ipsilateral
MNTB or the ipsilateral LNTB fiber tract 100 to 150 m away from the
somatic region of theMSO. An analog isolated pulse generator (BSI 950;
Dagan) at a rate of 0.2 Hz triggered a bipolar (/), paired stimulus
pulse (from here on referred to as test pulse) with an interstimulus inter-
val of 20ms. The threshold stimulus strength was typically 20–80 Vwith
pulse durations between 200 and 400 s.
IPSCs were pharmacologically isolated by bath application of the
AMPA receptor antagonist DNQX (10 M). EPSCs were evoked in the
presence of the glycine receptor antagonist strychnine (1 M). In all
experiments, DL-APV (50M)was applied to blockNMDA receptors and
SR95531 (10 M) to block GABAA receptors. To determine GABABR-
mediated effects, the corresponding agonist baclofen (1M) was applied
to the perfusate. This baclofen concentration is slightly above the IC50
values of the dose–response curve for the excitatory ([IC50] 0.62 M)
and inhibitory ([IC50]  0.2 M) inputs as measured in P14 animals
(supplemental Fig. 1, available at www.jneurosci.org as supplemental
material). Some of the train stimulation experiments were performed
under the presence of the synaptosomalGABAuptake blockerNO711 (pre-
ferred GAT-1 selectivity) to increase the residual GABA concentration dur-
ing MNTB or LNTB stimulation. Dependent on the hypothesis, baseline
conditions consisted in all experiments of 5minwith or without the 100Hz
trainpreceding the testpulse. In someexperiments, 4-AP(2mM)wasused to
raise spontaneous synaptic activity levels in the slice (supplemental Fig. 2,
available at www.jneurosci.org as supplemental material).
Data analysis. The signals were filtered with a low-pass four-pole
Bessel filter at 10 kHz, sampled at 20–50 kHz, and digitized using a
Digidata 1322A interface (Molecular Devices). Traces were digitally fil-
tered at 2–5 kHz. Stimulus generation, data acquisition, and off-line
analysis of data were performed using the pClamp Software (version
10.2; Molecular Devices). The paired-pulse ratio (PPR) was calculated as
the mean amplitude of the synaptic response evoked by the second stim-
ulus over that evoked by the first one. The coefficient of variation (CV)
was calculated as the ratio between the SD of synaptic current amplitude
and the mean amplitude (Faber and Korn, 1991). All data shown in
percentage reflect values normalized to baseline conditions. Figures,
which display averaged evoked responses, consist of at least 13 traces.
Stimulation artifacts have been deleted for clarity in figures that show
averaged traces. Results are expressed as mean  SEM. Significant dif-
ferences are marked as follows: *p 0.05, **p 0.01, and ***p 0.001.
Values of p in this study were obtained by using Student’s two-tailed
paired or unpaired t test.
Immunohistochemistry. Animals of different ages (P7, P18, P19, P30)
were deeply anesthetized with isoflurane and then perfused with 0.9%
Ringer’s solution (5 min) followed by 4% paraformaldehyde (PFA) (30
min). Brains were removed and postfixated in PFA overnight at 4°C. The
tissue was then sectioned at 40–60 m using a vibratome. Immunohis-
tochemistry was applied to free-floating sections. After extensive rinsing
in PBS, sections were exposed to a blocking solution (BS) containing 1%
bovine serum albumin, 0.5%Triton X-100, and 0.1% saponin in PBS (30
min). Subsequently, a double-immunofluorescence labeling was per-
formed with the following primary antibody combinations: guinea pig
anti-GABABR1 (1:2000; Millipore Bioscience Research Reagents)/
chicken anti-microtubule-associated protein 2 (MAP2) (1:1000; Neu-
romics) and guinea pig anti-glycine transporter 2 (GlyT2) (1:1000;
Millipore)/mouse anti-glutamate decarboxylase 65 (GAD65) (1:500;
Millipore Bioscience Research Reagents) in PBS, containing the same BS
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overnight at 4°C. The immunoreactivity was visualized by incubating the
sections with secondary antibodies raised in donkey and conjugated to
either Cy3 (1:300; Millipore Bioscience Research Reagents), Alexa 488
(1:200; Invitrogen), orCy5 (1:200;Dianova) in BS for 3 h at 37°C. Finally,
the sections were rinsed, mounted, and coverslipped with Vectashield
medium (Vector Laboratories). Confocal optical sections were acquired
with a Leica TCS SP confocal laser-scanning microscope (Leica Micro-
systems) equipped with PL FLUOTAR 25/0.75 numerical aperture
(NA) and HXC PL APO 63/1.32 NA oil-immersion objectives. Fluo-
rochromes were visualized using an argon laser with excitation wave-
lengths of 488 nm (emission, 510–540 nm) for Alexa 488, a DPSS laser
with a laser line of 561 nm (emission, 565–600 nm) for Cy3, and a
helium–neon laser with an excitation wavelength of 633 nm (emission,
640–760 nm) for Cy5. Stacks of 8 bit grayscale imageswere obtainedwith
axial distances of 300 or 1000 nm between optical sections and pixel sizes
of 310–781 nm depending on the selected objective. After stack acquisi-
tion, Z chromatic shift between color channels was corrected. RGB
stacks, montages of RGB optical sections, and average-intensity projec-
tions were created using ImageJ 1.37 k plug-ins.
Results
GABAB receptors modulate all four major inputs to
MSO neurons
Neurons in the MSO show strong immunoreactivity against
GABABRs (Fig. 1B, left). At higher magnification, this staining
appears punctuated with a distribution
over the entire cell body and along the
proximal dendrites (Fig. 1B, right), which
suggests a functional role of GABABRs in
MSO neurons. Using whole-cell voltage-
clamp recordings from MSO neurons in
acute brain slices, we investigatedwhether
pharmacological activation of GABABRs
modulates the excitatory and inhibitory
inputs to MSO neurons. These experi-
ments, as well as the immunolabeling in
Figure 1B, were performed in 19-d-old
animals, an age when the properties of the
excitatory and inhibitory inputs to the
MSO are considered to be adult-like
(Magnusson et al., 2005; Scott et al., 2005;
Sonntag et al., 2009). In adult animals,
MSO neurons receive two excitatory glu-
tamatergic inputs from the ipsilateral and
contralateral AVCN and two inhibitory
glycinergic inputs from the ipsilateral
MNTB and LNTB (Fig. 1A). IPSCs and
EPSCs were evoked by either stimulation
of the ipsilateral or contralateral fiber tract
to MSO neurons. Since the excitatory and
inhibitory inputs from each side run in
the same fiber bundle (Cant and Hyson,
1992; Kuwabara and Zook, 1992; Grothe
and Sanes, 1993; Smith et al., 1993), fiber
stimulation usually resulted in a mixed
excitatory/inhibitory response. For this
reason, EPSCs and IPSCs had to be iso-
lated pharmacologically by antagonizing
either the excitatory or the inhibitory
inputs, respectively (see Materials and
Methods). To find out whether GABABR
activation regulates MSO inputs, GABABRs
were pharmacologically activated by bath
application of baclofen (1 M), a concen-
tration that lies within the dynamic part of
the dose–response curve for excitatory and inhibitory currents
(supplemental Fig. 1, available at www.jneurosci.org as supple-
mental material). Both excitatory and inhibitory inputs project-
ing to theMSO profoundly decreased in amplitude on activation
of GABABRs by baclofen application (Fig. 1C–E) (MNTB: con-
trol, 6.9  1.2 nA; baclofen, 2.8  0.5 nA; n  7; LNTB:
control,1.7 0.5 nA; baclofen,0.8 0.2 nA; n 5; contra
AVCN: control,3.1 0.6 nA; baclofen,1.9 0.6 nA; n 7;
ipsi AVCN: control,3.3 1.0 nA; baclofen,2.1 0.6 nA; n
4). However, the relative decrease of current amplitude by ba-
clofen application was strongest for MNTB inputs, whereas the
excitatory inputs were significantly less affected (MNTB: 59.4
3.5%, n  7; contra AVCN: 42.2  5.8%, n  7; LNTB: 45.8 
9.2%, n  5; ipsi AVCN: 35.3  2.9%, n  4; MNTB-contra
AVCN: p 0.05;MNTB-ipsi AVCN: p 0.001) (Fig. 1F).On the
contrary, the time course (decay time) of both the inhibitory or
excitatory currents was not changed by pharmacological activa-
tion of GABABRs with baclofen (1 M) (data not shown).
The relative effect of GABABR activation on inhibitory and
excitatory currents changes during development
Before hearing onset, which occurs around P12, the MNTB pro-
jections to the LSO and the MSO undergo several structural and
Figure1. PharmacologicalactivationofGABABRsdepressesexcitatoryandinhibitorycurrentsatall fourmajor inputstotheMSO.A,The
MSOcircuitwith its respective inputs fromtheMNTB,LNTB,and ipsilateralandcontralateralAVCN(redafferents, excitatory;blueafferents,
inhibitory).B,FluorescentGABABRstainingoftheMSOinP19gerbils(red,GABABR1;green,MAP2).Left,GABABRswereexpressedalongthe
entire dorsoventral extent of theMSO. Scale bar, 50m.Right, Cytosolic aswell asmarginal GABABR1 stainingwas detectable. Scale bar,
10m.C,ExampletimecourseofIPSCamplitudedepressionduringbathapplicationofbaclofen(MNTBfiberstimulation).D,Exampletime
courseofEPSCamplitudedepressionduringbathapplicationofbaclofen (contralateralAVCNfiber stimulation).E, Top, IPSCsunder control
andbaclofenconditions.Bottom,EPSCsundercontrolandbaclofenconditions(examplesdisplayaveragedevokedresponses).F,Summary
and statistics of themodulatory effect of baclofen on current amplitude for all major inputs to the MSO. The asterisks represent p values
obtained by Student’s two-tailed unpaired t test. Error bars indicate SEM.
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functional changes. Most importantly,
these inputs change from a mixed GABA/
glycinergic to a pure glycinergic transmit-
ter phenotype (Kotak et al., 1998; Smith et
al., 2000; Kullmann et al., 2002; Nabekura
et al., 2004). In addition, this input
switches from being depolarizing to hy-
perpolarizing caused by a significant
decrease in the postsynaptic chloride con-
centration (Kandler and Friauf, 1995;
Kakazu et al., 1999; Lo¨hrke et al., 2005).
Our next goal was to determine whether
GABABRs might be involved in these
functional changes. Therefore, we quanti-
fied GABABR-induced input modulation
in MSO neurons considerably before
hearing onset (P9), shortly after hearing
onset (P14), at amoremature stage (P19),
and from mature animals (P32) by appli-
cation of baclofen (1 M). In all age
groups tested, baclofen depressed the in-
hibitory inputs evoked by MNTB fiber
stimulation. Interestingly, this GABABR-
mediated effect on the inhibitory inputs
remained approximately constant dur-
ing all developmental stages tested (P9:
48.2  4.5%, n  7; P32: 46.5  10.7%,
n  4) (Fig. 2A). In contrast, GABABR-
mediated depression of the excitatory,
glutamatergic inputs decreased signifi-
cantly after hearing onset (P9 contra
AVCN: 78.1  2.7%, n  5; P14 contra
AVCN: 47.4  2.8%, n  6; p  0.001)
(Fig. 2B). This decrease of GABABR-
mediated regulation of the excitatory in-
puts continued up to P32 when input
properties are generally considered to be
mature (P19 contra AVCN: 42.2  5.7%, n  7; P32 contra
AVCN: 19.6  2.5%, n  4; p  0.05) (Fig. 2B). Similar devel-
opmental changes of GABABR-mediated modulation of inputs
were observed for the projections from the LNTB (P9: 47.2 
4.2%, n 4; P19: 45.8 9.2%, n 5) and the ipsilateral AVCN
(P9: 71.8  4.9%, n  5; P19: 35.3  2.9%, n  4; p  0.001).
Together, these data suggest that, before hearing onset, GABABRs
more strongly regulate the excitation, whereas in the matured
system their effect mainly remains in regulating the inhibitory
input strength.
GABABR immunostaining changes from a predominantly
dendritic to a mostly somatic location during development
This developmental decrease of baclofen effect on the excitatory
MSO inputs was corroborated by immunostainings against the
GABABR1 subunit in fixed tissue sections at different develop-
mental stages (P7, P19, P30). In general, MSO neurons showed
antibody reactivity for GABABRs at all age groups tested (Fig.
2C). Nevertheless, differences between the age groups became
obvious by qualitatively comparing the distribution pattern of
GABABR staining with the general dendritic MAP2 staining. At
P7, GABABR staining was profound in the dendritic region me-
dial and lateral to the MSO somata, whereas the somatic region
was only slightly immunoreactive. In contrast, at P19 and even
more pronounced later during development (at P30), GABABR
immunoreactivity was considerably stronger at theMSO somata,
whereas an obvious decrease of dendritic staining was detectable
compared with gerbils before hearing onset. Physiological and
anatomical data together strongly indicate a developmental
change of the presynaptic GABABR distribution. During early
developmental stages, GABABRs seem to be mainly located on
the excitatory inputs, which mostly terminate on the dendrites
(Stotler, 1953; Clark, 1969; Russell and Moore, 1999). In more
mature animals, GABABRs seem to be predominantly located on
the presynaptic inputs at the soma, which are mostly glycinergic
and thus inhibitory (Kapfer et al., 2002).
At all developmental stages, GABABRs control transmitter
release probability on the excitatory and inhibitory inputs
to MSO principal neurons
In most cases, modulation of input strength by GABABR activa-
tion is achieved either by presynaptic changes in release proba-
bility or by postsynaptic activation of K-currents. Since in the
previous experiments postsynaptic potassium channels were
blocked pharmacologically (see Materials and Methods), the
above-described decrease in synaptic strength by baclofen appli-
cation is likely to be induced via activation of presynaptically
situated GABABRs. To test this hypothesis, we analyzed the PPRs
of evoked IPSCs and EPSCs before and during pharmacological
activation of GABABRs. For both excitation and inhibition, ba-
clofen significantly increased the PPR before (P9) and after hear-
ing onset (P19), most likely reflecting a reduction in transmitter
Figure 2. Physiological efficiency and anatomical distribution of GABABRs changes during maturation for excitatory but not
inhibitory inputs. A, Average decrease of normalized IPSC amplitudes by baclofen (1 M) for different age groups (MNTB fiber
stimulation).B, Average decrease of normalized EPSC amplitudes by baclofen (1M) for different age groups (contralateral AVCN
fiber stimulation). C, Top, Antibody labeling in the MSO against GABABR1 (red) and MAP2 (green) at different developmental
stages. Bottom, Isolated immunofluorescence of GABABR1. Scale bars, 50 m. The asterisks represent p values obtained by
Student’s two-tailed unpaired t test. Error bars indicate SEM.
9718 • J. Neurosci., July 21, 2010 • 30(29):9715–9727 Hassfurth et al. • GABAB Receptors in the Medial Superior Olive
release probability at the given presynaptic input (Fig. 3A). We
also analyzed the CV, an additional measurement to estimate
changes in presynaptic release probability, for all major MSO
inputs. Current amplitudes exhibited a stronger fluctuation in
peak sizes after application of baclofen (Fig. 3B). To visualize this
effect, we show a Gaussian function fitted to the IPSC amplitude
distribution evoked by MNTB stimulation. As for the PPR, ba-
clofen application increased the CV for excitatory and inhibitory
inputs before and after hearing onset. Finally, the mean fre-
quency of both, inhibitory and excitatoryminiature postsynaptic
currents (mIPSCs andmEPSCs) declined significantly during ba-
clofen application for both prehearing andmore mature animals
(Fig. 3C). FormEPSCs, this decline was significantly larger for P9
compared with P19 animals (P9: 57 6%, n 5; P19: 37 6%,
n  5; p  0.01), similar to the developmental changes in the
GABABR-induced reduction of eEPSC
amplitude. Consistent with our previous
study (Magnusson et al., 2005), we ob-
served a more than twofold increase in
mIPSC amplitude between P9 (45  2.1
pA; n  7) and P19 (99  10 pA; n  5)
( p 0.001), whereas mEPSC amplitudes
did not change during the same develop-
mental period (P9: 30  2.4 pA, n  5;
P19: 31 1.1, n 5). Together, these data
suggest that the observed reduction in in-
put strength by GABABR activation is
achieved by a decrease in transmitter re-
lease probability via presynaptic GABABRs
before hearing onset as well as later during
development.
GABAB receptor activation has a
postsynaptic effect in MSO neurons
only before hearing onset
GABABRs not only control transmitter re-
lease at the presynaptic terminal but also
change the conductance of postsynaptic
ion channels, thereby exerting inhibition
and altering the integrative properties of
neurons. In the majority of neurons,
postsynaptic GABABRs are directly cou-
pled to G-protein inwardly rectifying K
channels (GIRK channels). Activation of
postsynaptic GABABRs leads to an open-
ing of the GIRK channels and induces an
increase inK current.We testedwhether
pharmacological activation of GABABRs
activates a K current in MSO neurons,
by analyzing the currents evoked by a hy-
perpolarizing voltage ramp (duration, 900
ms; voltage change, 0.14 mV/ms) before
and during baclofen application (100
M). In prehearing animals (P9), the hy-
perpolarizing current ramp induced a net
inward current that, to a large part, con-
sists of the hyperpolarization activated
current (Ih) (Fig. 4A,B). At this age, the
average amplitude of pharmacologically
isolated Ih is 815  91 pA (n  11) (for
50 to110 voltage steps) (U. Koch and
B. Hassfurth, unpublished observation).
Activation of GABABRswith baclofen (100
M) in all neurons consistently and with a rapid onset changed
the holding current to more positive values and increased the
current evoked by the hyperpolarizing current ramp (Fig. 4B,C).
This is consistent with an activation of a K conductance, pre-
sumably a GIRK conductance. In more mature animals (P18),
the hyperpolarizing voltage ramp activated even larger Ih currents
(Khurana et al., 2008). To avoid that the large Ih obscured activa-
tion of GIRK currents, Ih was partially blocked by the specific Ih
antagonist ZD7288 (20 M), which does not block baclofen-
induced GIRK channel activation (Svoboda and Lupica, 1998;
Takigawa and Alzheimer, 2002). At this developmental stage, no
rapid change in holding current or evoked current was observed
during baclofen application (Fig. 4D,E). On average, there was a
slow but small increase in holding current and a decrease in
evoked current, which is mostly consistent with a slow and
Figure 3. GABABRs are located presynaptically at inhibitory and excitatory inputs to theMSO before and after hearing onset.A,
Left, PPRof IPSCs and EPSCs decreasedduring exposure to baclofen (examples display averaged evoked responses of P19neurons).
Right, Summary and statistics of baclofen (1M)-induced changes in PPR for all stimulation conditions in animals before (P9) and
after (P19) hearing onset. B, Left top, Single IPSCs (gray) illustrate the scatter around the mean (black) under control conditions
and during baclofen application in a P19 animal. Left bottom, Distribution of normalized IPSC amplitudes under control conditions
andduringbaclofen application. Gaussian fit for the variance of IPSC amplitudes around themeanbecamebroader duringbaclofen
application. Right, Quantification of CVs of normalized evoked postsynaptic currents (ePSCs) for control conditions and with
baclofen for the two age groups. C, Left, Example raw traces of mEPSCs under control conditions (black) and during baclofen
exposure (gray). Right, Quantification of frequency changes of inhibitory and excitatory miniature postsynaptic currents induced
by application of baclofen (1M). ctr, Control; BAC, baclofen. The asterisks represent p values obtained by Student’s two-tailed
paired t test. Error bars indicate SEM.
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gradual inactivation of the remaining Ih
(Fig. 4F). We conclude that, only before
hearing onset, activation of postsynaptic
GABABRs induces a change in postsynap-
tic conductances,most likely an activation
of GIRK. Several days after hearing onset,
GABABR activation does not alter postsyn-
aptic conductances. However, as indicated
by the intracellular GABABR immunoreac-
tivity, these receptors might be involved in
long-term changes of synaptic efficacy
(Kotak et al., 2001; Yevenes et al., 2003).
Before hearing onset, MNTB
fiber stimulation activates
presynaptic GABABRs
During early prehearing postnatal stages,
LSO and MSO neurons receive a mixed
GABAergic and glycinergic inhibition
from inputs originating from the MNTB,
whereas after hearing onset inhibitory
transmission from the MNTB is predom-
inantly glycinergic (Kotak et al., 1998;
Smith et al., 2000). Hence, we next asked
the question whether in young animals
(P8) GABA release fromMNTB fibers ac-
tivates GABABRs and thereby modulates
the glycinergic and/or glutamatergic in-
puts to MSO neurons. If, at this age,
MNTB neurons indeed release GABA to-
gether with glycine from their terminals,
this should activate GABABRs located
presynaptically on the same synapse and
thereby decrease the release probability of
the glycinergic transmission. This was
tested by analyzing the amplitude of the
glycinergic inhibitory currents in response
to a test stimulus 200 ms after a high-
frequency train stimulation ofMNTB fibers
(100 Hz, 200 ms) (Sodickson and Bean,
1996). If GABABRs were activated during
this high-frequency stimulation, the
GABABR antagonist SCH50911 (10 M)
should block the GABABR-induced de-
crease in transmitter release probability of the glycinergic input.
Surprisingly, pharmacological blockade of GABABRs did not in-
duce a significant change in the amplitude of the inhibitory cur-
rent at this developmental stage (7.8 5.6%; n 5) (Fig. 4A,E).
It is possible that, in P8 animals, the concentration of released
GABA is not sufficient to activate the presynapticGABABRswith-
out N0711 (Smith et al., 2000). However, even at P5, when stim-
ulation of the MNTB–MSO projection still elicits a substantial
GABAA receptor response (Smith et al., 2000), presynaptic GAB-
ABR activation in the absence of NO711was negligible (change in
IPSC amplitudewith SCH50911:5 9%, n 4). Also increas-
ing the duration of the stimulus train (500 ms) in P8 animals
did not yield a significant GABABR activation at the MNTB
inputs, but instead caused a slow depression of synaptic cur-
rents even in the presence of GABABR receptor blockers, most
likely induced by the long duration of fiber stimulation (change
in IPSC amplitude with SCH50911: 29  17%, n  3). This
suggested that high-frequency firing of the MNTB inputs
alone was not sufficient to elevate the GABA concentration
high enough to activate GABABRs effectively. However, per-
forming the same experiment but applying the GABA uptake
blocker NO711 (50M) to increase the overall GABA concentra-
tion, resulted in a significant decrease in the IPSC amplitude
(38.2 5.3%; n 5; p 0.01) (Fig. 5B,E). This decrease in IPSC
amplitude was completely abolished by the GABABR antagonist
SCH50911 (10 M) (1.8 4.7%; n 4) (Fig. 5C,E) and differed
significantly from application of NO711 alone ( p 0.01).
Before hearing onset, MNTB fibers also terminate on the den-
drites of MSO neurons (Kapfer et al., 2002; Werthat et al., 2008),
which receive the majority of excitatory inputs from the ipsilat-
eral and contralateral AVCN (Stotler, 1953; Clark, 1969; Russell
andMoore, 1999). Therefore, GABA released fromMNTB fibers
should potentially also activate GABABRs located on the excita-
tory presynaptic terminals, which at this developmental stage
show high sensitivity to very low concentrations of baclofen (Fig.
2B). Indeed, stimulating the fibers of the trapezoid body as in the
previous experiment in combination with the application of the
GABA uptake blocker NO711 resulted in a decrease of the exci-
Figure 4. Only before hearing onset baclofen activates a current in MSO neurons consistent with a K current. A, Example
traces of a current evoked by a hyperpolarizing voltage ramp (voltage change, 0.14 mV/ms) under control conditions and during
baclofen application (100M) in a P9 animal. B, Time course of averaged changes in holding current (top; n 4) and evoked
currents measured from the baseline of the holding current to the average current evoked during the last 100 ms of the voltage
ramp (bottom; n 4) induced by baclofen bath application in P9 animals. C, Averaged changes in holding current and control
conditions (3 min before baclofen application, black bars) and during baclofen application (5 min after the start of baclofen
application, gray bars) in P9 animals.D, SameasA, but in a P18animalwith additional ZD7288 (20M) applied to thebath toblock
the large Ih current. E, Same as B, but in P18 animals and with 20M ZD7288 applied to the bath. F, Same as in C, but in P18
animals. ctr, Control; BAC, baclofen. The asterisks represent p values obtained by Student’s two-tailed paired t test. Error bars
indicate SEM.
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tatory currents similar to that observed for the inhibitory currents
(25.7 8.0%; n 4; p 0.05) (Fig. 5E). This indicates that, before
hearing onset, GABA release most likely originating from MNTB
terminals controls transmitter release via GABABR activation of
both the excitatory and the inhibitory inputs of MSO neurons.
Several studies show that, even after hearing onset, MNTB
neurons release GABA from their synaptic terminals at their tar-
get sites (Kotak et al., 1998; Smith et al., 2000; Nabekura et al.,
2004). Yet these results are based on the
activation ofGABAA receptors induced by
MNTB fiber stimulation. Focusing on
GABABR, we asked whether at later devel-
opmental stages potential GABA release
from MNTB terminals could activate
GABABRs on the presynaptic terminals of
the MTNB inputs in animals just after
hearing onset. However, at P14, high-
frequency stimulation of trapezoid body
fibers in combination with NO711 appli-
cation had only marginal effects on gly-
cinergic IPSCs (4.1  3.3%; n  5) (Fig.
6C). Also, increasing the stimulus dura-
tion and frequency to 500 ms and 200 Hz
together with application of GABA up-
take blockers did not result in GABABR
activation on the inhibitory inputs after
hearing onset (change in IPSC amplitude
withSCH90511:7.1 5.7%, n 5). This
suggests that, after hearing onset, GABA
release from MNTB neurons is not suffi-
cient to activate GABABRs even in the
presence of GABA uptake blockers.
The LNTB–MSO projection has
no GABAergic component after
hearing onset
Previous anatomical studies provide ev-
idence that the ipsilateral inhibitory in-
put to the MSO, the LNTB, comprises
GABAergic neurons also in adult animals
(Roberts and Ribak, 1987; Helfert et al.,
1989; Spirou et al., 1998). Thus, we at-
tempted to find out whether the LNTB
could serve as a GABA source for the acti-
vation of GABABRs before hearing onset
and later during development. Accord-
ingly, we stimulated the ipsilateral fiber
tract projecting from the LNTB to the
MSO. At P8, the application of NO711
depressed glycinergic current ampli-
tudes to a similar degree as already ob-
served for MNTB fiber stimulation
(28.2  3.2%; n  6; p  0.001)
(Fig. 6A,C). At P14, however, high-
frequency stimulation of the LNTB fi-
bers in combination with NO711
application did not activate presynaptic
GABABRs on the inhibitory inputs
(NO711: 5.2  1.6%, n  5) (Fig.
6B,C). This suggests that, after hearing
onset, despite the presence of GABA-
immunopositive LNTB cells, LNTB in-
puts to the MSO do not provide enough
GABA to induce GABABR-mediated control of MSO inputs.
Presynaptic GABABRs are not activated by retrograde GABA
release in the MSO
We have previously demonstrated that neurons in the LSO ret-
rogradely release GABA on spiking activity (Magnusson et al.,
2008). This GABA activates presynaptic GABABRs on the respec-
tive inputs, thereby modulating transmitter release. Since neu-
Figure 5. Before hearing onset (P8), high-frequencyMNTB fiber stimulation activates GABABRs at the excitatory and inhibitory
MSO inputs, but only under the prerequisite of a GABA uptake inhibitor.A, Example traces of averaged IPSCs evoked byMNTB fiber
stimulation [stimulation protocol: high-frequency stimulation (100Hz, 200ms); 200ms gap; test pulsewith interstimulus interval
of 20 ms] under control conditions and during GABABR blockade with SCH50911. B, Example traces of averaged IPSCs evoked by
MNTB fiber stimulation (see A) under control conditions and during bath application of the GABA uptake inhibitor NO711. NO711
application decreased the response to the test pulse after high-frequency MNTB fiber stimulation. C, Blocking GABABRs abolished
the NO711-induced amplitude change after high-frequency MNTB fiber stimulation. D, Example traces of averaged EPSCs evoked
by AVCN fiber stimulation (stimulation protocol; see A) under control conditions and during bath application of the GABA uptake
inhibitor NO711. NO711 application decreased also excitatory currents after high-frequency fiber stimulation. E, Quantification of
the GABABR-mediated decrease in IPSC and EPSC amplitudes induced by high-frequency fiber stimulation during application of
GABABR blocker and/or GABA uptake inhibitor (all at P8). The asterisks under columns represent p values obtained by Student’s
two-tailed paired t test; the asterisks between columns represent p values obtained by Student’s two-tailed unpaired t test. Error
bars indicate SEM.
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rons in the LSO and the MSO receive
similar inputs, we tested whether this sce-
nario might also hold for MSO principal
cells. As in the LSO, this was tested by in-
ducing high-frequency spiking activity
(100–300 Hz; 500 ms) in MSO principal
cells by short current step injections well
above spiking threshold (1.5–2.5nA) (sup-
plemental Fig. 3A, available at www.
jneurosci.org as supplemental material). If
spiking activity retrogradely released
GABA and thereby activated presynaptic
GABABRs, the amplitude of the postsyn-
aptic potentials induced by fiber stimula-
tion should decrease and the PPR should
increase. However, neither the amplitude
nor the PPR of EPSPs or IPSPs were
changed by the preceding high-frequency
spiking activity of theMSOneurons (sup-
plemental Fig. 3B,C, available at www.
jneurosci.org as supplemental material).
This indicates that, unlike in the LSO,
spiking activity of MSO neurons does not
activate presynaptic GABABRs by pre-
sumed retrograde release of GABA. This is
also consistent with the lack of GABA and
GAD immunoreactivity in neurons of the
MSO (Roberts and Ribak, 1987).
Anatomical evidence for other
GABAergic input to MSO neurons
In the previous experiments, we found
that, after hearing onset, despite clear ev-
idence for pharmacological activation of
presynaptic GABABRs in adult animals, neither the MNTB nor
the LNTB input seems to release enough GABA to activate
these receptors. We also did not observe GABABR activation by
retrogradely released GABA from MSO principal neurons. To
identify possible other sources of GABA on MSO neurons, we
performed antibody stainings on paraformaldehyde-fixed brain-
stem sections containing the MSO (P18) against the GABA-
synthesizing enzyme GAD65. To evaluate the distribution of
GAD65-positive inputs, the dendrites of MSO neurons were vi-
sualized with a MAP2 antibody. Confocal microscopy at low
magnification showed widely distributed GAD65 staining along
the somata and dendrites of MSO neurons, indicating the pres-
ence of GABAergic inputs at the soma and the dendrites. We also
tested whether possible GABAergic inputs colocalized with the
presynaptic endings deriving from the MNTB or LNTB by im-
munostaining against GlyT2 (Fig. 7A). In contrast to the GAD65
distribution, the GlyT2 staining was very focused and dense only
on the somata. At higher magnification, it became apparent that
only little colocalization of GAD65- and GlyT2-positive synapses
could be detected. Most of the GAD65-associated staining was
not in close proximity to GlyT2-positive terminal endings. This
indicates that MSO neurons at P18 receive GABAergic projec-
tions mainly from other sources than the glycinergic MNTB or
LNTB neurons.
Raising spontaneous activity levels induces GABABRs
activation even later during development
We next asked the question whether these GABAergic terminals
could serve as a possible source for GABA release that activates
the GABABRs located on theMSO inputs. To test this, spontane-
ous synaptic transmitter release was increased by applying 4-AP
(2 mM) to the perfusate. 4-AP is a nonselective blocker of low-
threshold potassium channels (KLT) and has been shown to de-
polarize neurons, thereby lowering the action potential threshold
and increasing the spontaneous firing rate in, for example, the hip-
pocampus andmouse inner hair cells (Avoli et al., 1996;Marcotti et
al., 2003). In the present experiment, 4-AP elevated the sponta-
neous frequency of IPSCs in MSO neurons (55.8 2.9 Hz; n
23) to values that resemble in vivo-like spontaneous firing fre-
quencies ofMNTBneurons (Kopp-Scheinpflug et al., 2003, 2008;
Hermann et al., 2007; McLaughlin et al., 2008). The influence of
possible GABA release through elevated spontaneous release was
now tested by application of the GABABR inhibitors SCH50911
(10 M) or CGP55845 (2 M). The results from these recordings
were pooled since the data displayed no differences among drugs.
MNTB fibers were stimulated to investigate GABABR-induced
changes of MNTB input currents. As depicted in Figure 7B, IPSC
amplitudes significantly increased when GABABR activity was
blocked compared with baseline conditions (4-AP alone). This
implies that, under baseline conditions, when spontaneous activ-
ity is raised by 4-AP, presynaptic GABABRs were endogenously
activated, which resulted in a reduction of IPSC amplitudes. Ap-
plication of the GABABR antagonists then abolished this
GABABR-mediated depression of the current, resulting in an in-
crease of current amplitude (22.3 4.2%; n 16; p 0.01) (Fig.
7C). Since neither 4-AP (6.9  7.6%; n  8) nor GABABR
inhibitors alone (3.8  5.9%; n  4) increased peak current
amplitudes (Fig. 7C), this effect could be ascribed directly to the
Figure 6. High-frequency LNTB fiber stimulation only activates GABABRs before but not after hearing onset. Similar to the
MNTB, GABABRs are only activatedunder the prerequisite of theGABAuptake inhibitor NO711.A, Example traces of averaged IPSCs
evoked by LNTB fiber stimulation (stimulation protocol same as in Fig. 4A) under control conditions and together with the GABA
uptake inhibitor NO711 in a prehearing animal (P8). B, Example traces of averaged IPSCs evoked by LNTB fiber stimulation
(stimulation protocol same as in Fig. 4A) under control conditions and together with the GABA uptake inhibitor NO711 in animals
after hearingonset (P14).C, Statistical analysis of GABABR-mediated changes in IPSC amplitude in response to the test pulse before
and after hearing onset for MNTB and LNTB inputs to the MSO. The asterisks represent p values obtained by Student’s two-tailed
paired t test. Error bars indicate SEM.
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activation of GABABRs. No differencewas
observed between P14 and P18 gerbils,
which indicates that this mechanism per-
sists inmoremature animals (P14: 21.3
5.0%, n  9; P18: 23.5  7.8%, n  7)
(Fig. 7D). Interestingly, excitatory input
currents did not display an increase in
amplitude during GABABR blockade
which suggests that the GABA released by
spontaneous activity did not activate the
GABABRs on the excitatory inputs (Fig.
7E) (P14–P18:5.6 6.6%, n 9) (Fig.
7C). This is in line with the observed
downregulation of GABABRs on the den-
drites later during development. Together,
these results show that, even considerably
beyond hearing onset, GABA is released
onto MSO neurons, which selectively
modulates the amplitude of the inhibitory
inputs. The origin and thus the activation
pattern of this GABAergic projection
needs to be determined in future studies.
Discussion
The data presented here show that GABABRs
differentially modulate the excitatory
and inhibitory inputs ofMSOneurons at all
developmental stages. Around hearing on-
set, the GABABR-mediated depression of
the excitatory inputs greatly decreases,
whereas the GABABR-mediated depression
of the inhibitory inputs remains constant
throughout the same period. This develop-
mental decay in GABABR-induced EPSC
depression is paralleled by a progressive
loss of GABABR expression in dendrites
of MSO neurons after hearing onset.
During the same developmental period,
we also observe a loss of postsynaptic
GABAB receptor-induced K
 current
increase. Furthermore, we provide evi-
dence that the source ofGABA forGABABR
activationchangesduringdevelopment.Be-
fore hearing onset, MNTB and LNTB fiber
stimulation activates presynaptic GABABRs
on the excitatory and inhibitory inputs to
MSOneurons.Afterhearingonset,GAD65-
positive endings often lack GlyT2 reactivity,
suggesting GABA sources other than the
MNTB or the LNTB.
Developmental changes in GABABRs
distribution and function
We have found that, throughout all de-
velopmental stages, GABABRs regulate
transmitter release at themajor inhibitory
and excitatory inputs to MSO neurons.
Yet the relative effect of GABABRs on ex-
citation and inhibition changes during the
first postnatal weeks. Regulation of trans-
mitter release by presynaptic GABABRs is
a widespread mechanism in the brain and
has been described in several auditory re-
Figure 7. GABAergic inputs to the MSO after hearing onset are not colocalized with glycinergic inputs. Increasing
spontaneous activity pharmacologically in slice preparations to in vivo-like levels activates GABABRs with a significant
effect on inhibitory inputs. A, Top, Low-power (25) magnification of antibody staining in P18 animals revealed a
somatodendritic expression of GAD65 (green), whereas GlyT2 (red) was concentrated at the somatic region. Scale bar, 50
m. Bottom, At high-power magnification (63), colocalization of GAD65 and GlyT2 was scarce. Scale bar, 10 m. B,
Time course of averaged IPSC amplitudes (n  16) evoked by MNTB fiber stimulation under in vivo-like spontaneous
synaptic activity levels before and during GABABR blocker application (the arrow indicates the start of GABABR blocker
application). During the entire time course, spontaneous activity levels had been raised by 4-AP (2 mM) in the bath, which
had no effect on IPSC amplitudes (n 8). C, Summary and statistics on the effect of in vivo-like spontaneous activity levels
on GABABR activation for IPSCs and EPSCs in P14 –P18 animals. D, IPSC amplitudes of P14 and P18 animals are equally
affected by GABABR activation. E, Time course of averaged EPSC amplitudes (n 9) evoked by AVCN fiber stimulation
under in vivo-like spontaneous activity levels before and during GABABR blocker application (the arrow indicates the start
of GABABR blocker application). During the entire time course, spontaneous activity levels had been raised by 4-AP (2 mM)
in the bath. The asterisks under columns represent p values obtained by Student’s two-tailed paired t test; the asterisks
between columns represent p values obtained by Student’s two-tailed unpaired t test. Error bars indicate SEM.
Hassfurth et al. • GABAB Receptors in the Medial Superior Olive J. Neurosci., July 21, 2010 • 30(29):9715–9727 • 9723
gions, such as the auditory brainstem (Isaacson, 1998; Takahashi
et al., 1998; Lim et al., 2000; Yamauchi et al., 2000; Magnusson et
al., 2008; Tang et al., 2009), midbrain (Sun et al., 2006), and the
auditory cortex (Wehr and Zador, 2005). Furthermore, GABABRs
have been implicated both in the regulation of circuit formation
during development (Behar et al., 2000; Represa andBen-Ari, 2005)
and in the acute modulation of network properties in the mature
animal (Scanziani, 2000; Magnusson et al., 2008; Oswald et al.,
2009; Pan et al., 2009). Consistent with our data, anatomical and
physiological studies inotherbrain structures suggest thatpresynap-
ticGABABRsarepresent and functional onexcitatory and inhibitory
inputs during early development and in adult animals (Gaiarsa et al.,
1995; Varela et al., 1997; Lo´pez-Bendito et al., 2002; Kirmse and
Kirischuk, 2006). However, there is little information on changes in
GABABR function during development. Here, we show that
GABABR-mediated depression of the excitatory inputs declined sig-
nificantly right after hearing onset with an additional decline over
several weeks. In contrast, we observed that GABABR-mediated de-
pression of inhibition remains constant during development similar
to the CA3 region of the hippocampus (Caillard et al., 1998). In
contrast, activation of K-currents by postsynaptic GABAB recep-
tors, which is abundant in hippocampal and cortical neurons in
adult animals (BuonomanoandMerzenich, 1998; Scanziani, 2000;
Chen and Johnston, 2005; Oswald et al., 2009), disappears after
hearing onset in neurons of theMSO. Thus, the integrative prop-
erties of matureMSO neurons seem to be unaffected by postsyn-
aptic GABABRs, as previously observed for neurons in the lateral
superior olive (Magnusson et al., 2008).
An important question arising from this is how developmen-
tal changes inGABABRdistribution are regulated.One possibility
is that the decline in GABABR number is genetically determined.
However, it is more likely that overall activity levels regulate the
availability of GABABRs. Indeed, excess excitation and aug-
mented glutamate levels can downregulate GABABR expression
and increase internalization of the receptor protein (Buhl et al.,
1996; Haas et al., 1996; Vargas et al., 2008), which in both cases
would result in an altered GABABR efficacy as observed for exci-
tatory MSO inputs.
MNTB and LNTB fiber stimulation activates GABABRs in the
MSO only before hearing onset
Our data indicate that, before hearing onset, high-frequency fir-
ing of MNTB neurons activates GABABRs on both the excitatory
and inhibitory inputs toMSO neurons. Similarly, previous phys-
iological data show that, before hearing onset, MNTB fiber stim-
ulation also activates postsynaptic GABAA receptors on MSO
neurons (Smith et al., 2000). This suggests that indeed GABA
released from the MNTB fiber terminals activates presynaptic
GABABRs. The fact that at theMNTB–LSOprojectionGABA and
glycine are released from the same synaptic terminals or vesicles
(Nabekura et al., 2004) indicates that GABABR-mediated regula-
tion of glycine and GABA transmitter release is autosynaptic and
should therefore be similar for both transmitter types. Conse-
quently, during prolonged firing of MNTB neurons, GABA re-
lease should decrease and GABABR activation of the inputs
should decline in a self-regulating process.
As GABA is released from inhibitory MNTB terminals and
diffuses to excitatory presynaptic sites, GABABR-mediated de-
pression of excitation is most likely heterosynaptic. Heterosyn-
aptic activation of GABABRs has been shown to occur at many
different sites in the brain (Lim et al., 2000; Mitchell and Silver,
2000; Lei and McBain, 2003; Guetg et al., 2009). In the MSO, the
relatively large distance between the release sites and the excita-
tory presynaptic endings should result in much lower concentra-
tions of GABA at the excitatory compared with the inhibitory
terminals (Kapfer et al., 2002). Why then is the amplitude of
GABABR-mediated depression similar for inhibition and excita-
tion? One possible explanation is a differential sensitivity of the
receptors to GABA, which might be the underlying cause for the
larger effect of baclofen on excitation than inhibition observed
before hearing onset. Such a mechanism operates in the hip-
pocampus, in which heterosynaptic GABABRs located on the ex-
citatory inputs are indeed more efficient in downregulating
transmitter release compared with the GABABRs on the inhibi-
tory inputs because of a different subunit composition (Guetg et
al., 2009).
One unexpected result of our measurements was that, even
several days before hearing onset, MNTB fiber stimulation only
activated presynaptic GABABRs in the presence of the GABA
uptake blocker NO711. In general, physiological activation of
GABABRs usually requires strong stimulation intensities suggest-
ing that the pooling of synaptically released GABA is required for
their activation (Isaacson, 1998; Scanziani, 2000). This is consis-
tent with ultrastructural data showing that most GABABRs are
located perisynaptically or extrasynaptically (Fritschy et al., 2004;
Lo´pez-Bendito et al., 2004; Luja´n and Shigemoto, 2006). Indeed,
in many studies using acute brain slice preparations GABA up-
take blockers were required to activate presynaptic GABABRs
(Mouginot et al., 1998; Mitchell and Silver, 2000; Lei and
McBain, 2003). This also highlights the important role of GABA
uptake mechanisms for the regulation of GABA concentration.
An alternative mechanism for the lack of effect with low GABA
concentrationsmight be amasking of the change in release prob-
ability by an increased readily releasable pool as observed for
metabotropic glutamate receptor (mGluR) activation in the
MNTB (Billups et al., 2005). In this case, mGluR effects became
apparent through a decrease in recovery time constants. How-
ever, in our experiments, train stimulation without NO711 did
not seem to change the recovery time constant, whenwe analyzed
PSC amplitudes 200 ms after the termination of the train, a time
interval usually well within the range of recovery from synaptic
depression.
Endogenous GABABR activation in theMSO after
hearing onset
All previous studies so far had focused on the developmental
reduction in the activation of ionotropic GABAA receptors by
MNTB fiber activity (Kotak et al., 1998; Smith et al., 2000). Our
study indicates that presynaptic GABABRs cannot be activated by
eitherMNTB or LNTB fiber stimulation after hearing onset. Fur-
thermore, unlike in the LSO, spiking activity of MSO neurons
does not retrogradely activate GABABRs on the presynaptic ter-
minals. Under which physiological conditions are the GABABRs
in the MSO then activated? In agreement with previous anatom-
ical studies (Roberts and Ribak, 1987; Helfert et al., 1989; Adams
and Mugnaini, 1990), our antibody labeling against the GABA-
synthesizing enzyme GAD65 revealed a large number of
GABAergic fibers contacting the soma and the proximal den-
drites. We therefore propose that GABA released from these
GAD65-positive terminals mediates the GABABR-induced
depression of inhibitory inputs. But where do these GAD65-
positive fibers originate, and under which physiological circum-
stances are they activated? Several possibilities have been
discussed in the literature, including the ventral nucleus of the
trapezoid body, the superior paraolivary nucleus, and descending
fibers from the inferior colliculus (Roberts and Ribak, 1987). The
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experimental evidence for any of these projections is sparse
(Schwartz and Wittebort, 1976; Kiss and Majorossy, 1983), and
future experiments are required to determine the origin of the
GABAergic terminals to MSO neurons in adult animals.
Possible functional significance of GABABRs in theMSO
before and after hearing onset
The observed shift in the effect of GABABR-mediated depression
of excitation and inhibition suggests a change of GABABR func-
tion before and after hearing onset. Before hearing onset, we
found a profounddepression of the excitatory inputs byGABABR
activation, which indicates a block of activity by GABABR activa-
tion. At this age, also inhibitory inputs are affected by GABABR
activity. The functional interpretation of the GABABR-mediated
depression of inhibitory inputs before hearing onset is more
complex. In neonatal animals, the chloride reversal is positive to
the restingmembrane potential, which results in a depolarization
of neurons during activation of the GABA/glycinergic inputs
(Kandler and Friauf, 1995; Kakazu et al., 1999; Lo¨hrke et al.,
2005). Hence, during this period, themain inputs to theMSO are
excitatory. Accordingly, GABABRs might be the main source of
inhibition in the MSO by decreasing transmitter release from
both the glutamatergic excitatory and the depolarizing GABA/
glycinergic inputs during periods of high spontaneous spiking
activity. This scenario has previously been suggested for the neo-
natal hippocampal network (Gaiarsa et al., 1995; McLean et al.,
1996) and could represent an effective mechanism to prevent
overexcitation and apoptosis of neurons in the neonatal brain. In
this case, the GABABR-mediated inhibition of excitation should
remain elevated in deafened animals in which the chloride rever-
sal potential remains depolarizing in neurons of the LSO (Shibata
et al., 2004).
Our findings indicate that the function of presynaptic
GABABRs changes after hearing onset. First, at this developmen-
tal stage, GABABR activation mostly modulates the strength of
the inhibitory inputs to the MSO. Second, whereas in neonatal
animals GABA is released during high-frequency firing ofMNTB
and LNTB neurons, our data suggest that, after hearing onset,
fibers other than the MNTB or LNTB release GABA. Whether
these fibers are driven by sound or whether they are associated
with an attention-driven descending system is unclear at the mo-
ment, but in both cases activation of these fibers should result in
a tonic downregulation of the inhibitory inputs to the MSO. We
do know from previous experiments that the inhibitory inputs
from theMNTB andLNTB to theMSOmodulate ITDprocessing
by shifting the steepest slope of the ITD function into the physi-
ologically relevant range (Brand et al., 2002; Pecka et al., 2008).
Activation ofGABABRs on the excitatory and inhibitory inputs to
the MSO could fine-tune ITD analysis in several ways. A reduc-
tion in EPSC amplitude could sharpen the coincidence detection
window in response to binaural stimuli (Kuba et al., 2002). How-
ever, the main effect of GABABRs in adult animals clearly lies in
the downregulation of the inhibitory inputs. Given the presump-
tive role of inhibition for ITD coding, a reduction in IPSC ampli-
tude would move the peak of the ITD function closer to the
midline and thereby decrease spike frequency changes within the
physiologically relevant range. Moreover, for both the excitatory
and the inhibitory inputs, constituent GABABR activation atten-
uates short-term synaptic depression (Brenowitz et al., 1998) and
might be one of the underlying causes for the observed lack of
synaptic short-term depression in the in vivo preparation, as
observed in MNTB neurons (Lorteije et al., 2009). In general,
GABABR activation on the inputs to the MSO would provide a
mechanism to dynamically adjust ITD analysis in less than a
second.
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